PharMerica Sets New 52-Week High at $30.45 (PMC)
PharMerica (NYSE:PMC)’s share price hit a new 52-week high on Friday , StockRatingsNetwork reports. The stock traded as high as $30.45 and last traded at $30.43, with a volume of 320,867 shares trading hands. The stock had previously closed at $28.28.
A number of research firms have recently commented on PMC. Analysts at Zacks downgraded shares of PharMerica from an “outperform” rating to a “neutral” rating in a research note on Wednesday. They now have a $31.40 price target on the stock. Finally, analysts at Barclays reiterated an “underweight” rating on shares of PharMerica in a research note on Friday, May 2nd. They now have a $26.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. PharMerica has an average rating of “Hold” and an average price target of $23.77.
The stock has a 50-day moving average of $27.49 and a 200-day moving average of $24.70. The company has a market cap of $892.0 million and a P/E ratio of 64.13.
PharMerica (NYSE:PMC) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.37 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.33 by $0.04. The company had revenue of $452.20 million for the quarter, compared to the consensus estimate of $417.76 million. During the same quarter in the prior year, the company posted $0.46 earnings per share. The company’s quarterly revenue was up 2.8% on a year-over-year basis. Analysts expect that PharMerica will post $1.49 EPS for the current fiscal year.
PharMerica Corporation is an institutional pharmacy services company, which services healthcare facilities and provides management pharmacy services to hospitals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.